Atypical mitoses in lesions of the oral mucosa: A new interpretation of their impact upon tumorigenesis

European Journal of Cancer Part B: Oral Oncology

Volumn 33, Issue 2, 1997, Pages 110-118

  Steinbeck, Rüdiger G ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE   (Germany)

Author keywords

CDF classification; Endoreplication; Feulgen DNA; Hyperplasia; Microphotometry; Neoplasia; Oral mucosa

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; DNA CONTENT; FEULGEN STAINING; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; MAJOR CLINICAL STUDY; MOUTH MUCOSA; PHOTOMETRY; PRECANCER; PRIORITY JOURNAL; TUMOR GROWTH;

CELL DIFFERENTIATION; DNA; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTERPHASE; MITOSIS; MITOTIC INDEX; MOUTH MUCOSA; MOUTH NEOPLASMS; PLOIDIES; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0031105560     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-1955(96)00068-1     Document Type: Article

References (36)

1. 1. Shafer, W. G. and Waldron, C. A., A clinical and histopathologic study of oral leukoplakia. Surgical Gynecology and Obstetrics, 1961, 112, 411-415.
2. 2. Pindborg, J. J., Renstrup, G., Poulsen, H. E. and Silverman, S., Studies in oral leukoplakia. V: Clinical and histological signs of malignancy. Acta Odontologica Scandinavica, 1963, 21, 407-411.
3. 3. Burkhardt, A., Maerker, R., Löning, T. and Seifert, G., Dysplasieklassifikation oraler Leukoplakien und Präkanzerosen: Definition and praktische Anwendung. Deutsche Zeitschnft für Mund-, Kiefer- und Gesichts-chirurgie, 1978, 2, 221-231.
4. 4. WHO. Histological Typing of Female Genital Tracts Tumours, 2nd edn. Springer, Berlin, 1981.
5. 5. Soost, H.-J., Befundwiedergabe in der gynäkologischen Zytodiagnostik: Münchner Nomenklatur, II. Gynäkologische Praxis, 1990, 14, 433-438.
6. 6. Naujoks, H. F., Köpf, F. and Leber, J., Präoperative kolposkopisch-zytologische Diagnostik bei zervikaler intraepithelialer Neoplasie (CIN). Geburtshilfe und Frauenheilkunde, 1979, 39, 372-377.
7. 7. Richart, R. M., A modified terminology for cervical intra-epithelial neoplasia. Obstetrics and Gvnecology, 1990, 75, 131-133.
8. 8. Solomon, D., The 1988 Bethesda system for reporting cervical/ vaginal cytologic diagnoses. Acta Cytologica, 1989, 33, 567-574.
9. 9. Solomon, D., The revised Bethesda system for reporting cervical/vaginal cytologic diagnoses: Report of the 1991 Bethesda workshop. Acta Cytologica, 1992, 36, 273-276.
10. 10. Steinbeck, R. G., Heselmeyer, K. M., Moberger, H. B. and Auer, G. U., The relationship between proliferating cell nuclear antigen (PCNA), nuclear DNA content and mutant p53 during genesis of cervical carcinoma. Acta Oncologica, 1995, 34, 171-175.
11. 11. Steinbeck, R. G., Proliferation and DNA aneuploidy in mild dysplasia imply early steps of cervical carcinogenesis. Acta Oncologica., 1997, 36, 3-12.
12. 12. Steinbeck, R. G., Moege, J., Heselmeyer, K. M., Klebe, W., Neugebauer, W., Borg, B. and Auer, G. U., DNA content and PCNA immunoreactivity in oral precancerous and cancerous lesions. Oral Oncology, European Journal of Cancer, 1993, 29B, 279-284.
13. 13. Miyachi, K., Fritzler, M. J. and Tan, E. M., Autoantibody to a nuclear antigen in proliferating cells. Journal of Immunology, 1978, 121, 2228-2234.
14. 14. Bravo, R., Frank, R., Blundell, P. A. and MacDonald-Bravo, H., Cyclin/PCNA is the auxiliary protein of DNA polymerase delta. Nature, 1987, 326, 515-517.
15. 15. Crawford, L., The 53,000-dalton cellular protein and its role in transformation. International Review of Experimental Pathology, 1983, 25, 1-6.
16. 16. Lane, D. P., p53 and human cancers. British Medical Bulletin, 1994, 50, 582-599.
17. 17. Marx, J., How p53 suppresses cell growth. Science, 1993, 262, 1644-1645.
18. 18. Auer, G. U., Heselmeyer, K. M., Steinbeck, R. G., Munck-Wikland, E. and Zetterberg, A. D., The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma. Virchows Archives, 1994, 424, 343-347.
19. 19. Geitler, L., Endomitose und endomitotische Polyploidisierung. In Heilbrunn L. V., Weber F., eds. Protoplasmatologia: Handbuch der Protoplasmaforschung, Vol. 6c. Springer, Wien, 1953.
20. 20. Nagl, W., Endopolyploidy and Polyteny in Differentiation and Evolution. Elsevier, Amsterdam, 1978.
21. 21. Brodsky, V. Y. and Uryvaeva, I. V. Genome Multiplication in Growth and Development: Biology of Polypoid and Polytene Cells. Cambridge University Press, Cambridge, 1985.
22. 22. Sandritter, W., Methods and results in quantitative cytochemistry. In Wied G. L. ed. Introduction to Quantitative Cytochemistry, vol. I. Academic Press, New York, 1966, 159-181.
23. 23. Hiddemann, W., Schumann, J., Andreeff, M., Barlogie, B., Herman, C. J., Leif, R. C., Mayall, B. H., Murphy, R. F. and Sandberg, A. A., Convention on nomenclature for DNA cytometry. Cytometry, 1984, 5, 445-446.
24. 24. Ried, T., Knutzen, R., Steinbeck, R., Biegen, H., Schröck, E., Heselmeyer, K., Du Manoir, S. and Auer, G., Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes, Chromosomes and Cancer, 1996, 15, 234-245.
25. 25. Moore, G. E. and Woods, L. K., Culture media for human cells: RPMI 1603, RPMI 1634, RPMI 1640 and GEM 1717. Tissue Culture Association Manual. 3, 1976. 503-508.
26. 26. Steinbeck, R. G., Heselmeyer, K. M., Neugebauer, W. F., Falkmer, U. G. and Auer, G. U., DNA ploidy in human colorectal adenocarcinomas. Analytical and Quantitative Cytology and Histology, 1993B, 15, 187-194.
27. 27. Therman, E. and Susman, M., Human Chromosomes: Structure, Behavior, and Effects. 3rd edn. Springer, Heidelberg, 1993.
28. 28. Gerdes, J., Schwab, U., Lemke, H. and Stein, H., Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. International Journal of Cancer, 1983, 31, 13-20.
29. 29. Shimoyama, Y., Hirohashi, S., Hirano, S., Noguchi, M., Shimosato, Y., Takeichi, M. and Abe, O., Cadherin cell-adhesion molecules in human epithelial tissue and carcinoma. Cancer Research, 1989, 49, 2128-2133.
30. 30. Jankowski, J. A., Newham, P. M., Kandemir, O., Hirano, S., Takeichi, M. and Pignatelli, M., Differential expression of E-cadherin in normal, metaplastic and dysplastic oesophageal mucosa: a putative biomarker. International Journal of Oncology, 1994, 4, 441-448.
31. 31. Waldman, T., Lengauer, C., Kinzler, K. W. and Vogelstein, B., Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature, 1996, 381, 713-716.
32. 32. Owens, W., Field, J. K., Howard, P. J. and Stell, P. M., Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck. Oral Oncology, European Journal of Cancer, 1992, 28B, 17-21.
33. 33. Kallioniemi, A., Kallioniemi, O.-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F. and Pinkel, D., Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science, 1992, 258, 818-820.
34. 34. Timonen, S. and Therman, E., The changes in the mitotic mechanism of human cancer cells. Cancer Research, 1950, 10, 431-439.
35. 35. Oksala, T. and Therman, E., Mitotic abnormalities and cancer. In German J. ed. Chromosomes and Cancer. Wiley, New York, 1974, 239-263.
36. 36. Nowell, P. C., The clonal evolution of tumor cell populations. Science, 1976, 194, 23-28.